Table of Content

Table of Contents

Global Dermatomycoses Drug Market Segment Research Report 2021
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Dermatomycoses Drug Market by Value
2.2.1 Global Dermatomycoses Drug Revenue by Type
2.2.2 Global Dermatomycoses Drug Market by Value (%)
2.3 Global Dermatomycoses Drug Market by Production
2.3.1 Global Dermatomycoses Drug Production by Type
2.3.2 Global Dermatomycoses Drug Market by Production (%)

3. The Major Driver of Dermatomycoses Drug Industry
3.1 Historical & Forecast Global Dermatomycoses Drug Demand
3.2 Largest Application for Dermatomycoses Drug (2017-2027)
3.3 The Major Downstream Company in China Market 2021

4. Global and Regional Dermatomycoses Drug Market
4.1 Regional Market Size in Terms of Production & Demand (2021)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of Dermatomycoses Drug Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Dermatomycoses Drug Production, Demand (2017-2027)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe Dermatomycoses Drug Production, Demand (2017-2027)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China Dermatomycoses Drug Production, Demand (2017-2027)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan Dermatomycoses Drug Production, Demand (2017-2027)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India Dermatomycoses Drug Production, Demand (2017-2027)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea Dermatomycoses Drug Production, Demand (2017-2027)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia Dermatomycoses Drug Production, Demand (2017-2027)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global Dermatomycoses Drug Average Price Trend
12.1 Market Price for Each Type of Dermatomycoses Drug in US (2017-2021)
12.2 Market Price for Each Type of Dermatomycoses Drug in Europe (2017-2021)
12.3 Market Price for Each Type of Dermatomycoses Drug in China (2017-2021)
12.4 Market Price for Each Type of Dermatomycoses Drug in Japan (2017-2021)
12.5 Market Price for Each Type of Dermatomycoses Drug in India (2017-2021)
12.6 Market Price for Each Type of Dermatomycoses Drug in Korea (2017-2021)
12.7 Market Price for Each Type of Dermatomycoses Drug in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
13.1 Dermatomycoses Drug Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of Dermatomycoses Drug

14. Dermatomycoses Drug Competitive Landscape
14.1 Anacor Pharmaceuticals Inc
14.1.1 Anacor Pharmaceuticals Inc Company Profiles
14.1.2 Anacor Pharmaceuticals Inc Product Introduction
14.1.3 Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales, Revenue (2017-2021)
14.1.4 Strategic initiatives
14.2 Biolab Farmaceutica Ltda
14.2.1 Biolab Farmaceutica Ltda Company Profiles
14.2.2 Biolab Farmaceutica Ltda Product Introduction
14.2.3 Biolab Farmaceutica Ltda Dermatomycoses Drug Sales, Revenue (2017-2021)
14.2.4 Strategic initiatives
14.3 Blueberry Therapeutics Ltd
14.3.1 Blueberry Therapeutics Ltd Company Profiles
14.3.2 Blueberry Therapeutics Ltd Product Introduction
14.3.3 Blueberry Therapeutics Ltd Dermatomycoses Drug Sales, Revenue (2017-2021)
14.3.4 Strategic initiatives
14.4 Daewoong Pharmaceutical Co Ltd
14.4.1 Daewoong Pharmaceutical Co Ltd Company Profiles
14.4.2 Daewoong Pharmaceutical Co Ltd Product Introduction
14.4.3 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales, Revenue (2017-2021)
14.4.4 Strategic initiatives
14.5 Dermala Inc
14.5.1 Dermala Inc Company Profiles
14.5.2 Dermala Inc Product Introduction
14.5.3 Dermala Inc Dermatomycoses Drug Sales, Revenue (2017-2021)
14.5.4 Strategic initiatives
14.6 Helix BioMedix Inc
14.6.1 Helix BioMedix Inc Company Profiles
14.6.2 Helix BioMedix Inc Product Introduction
14.6.3 Helix BioMedix Inc Dermatomycoses Drug Sales, Revenue (2017-2021)
14.6.4 Strategic initiatives
14.7 Novan Inc
14.7.1 Novan Inc Company Profiles
14.7.2 Novan Inc Product Introduction
14.7.3 Novan Inc Dermatomycoses Drug Sales, Revenue (2017-2021)
14.7.4 Strategic initiatives
14.8 Sol-Gel Technologies Ltd
14.8.1 Sol-Gel Technologies Ltd Company Profiles
14.8.2 Sol-Gel Technologies Ltd Product Introduction
14.8.3 Sol-Gel Technologies Ltd Dermatomycoses Drug Sales, Revenue (2017-2021)
14.8.4 Strategic initiatives
14.9 TGV-Laboratories
14.9.1 TGV-Laboratories Company Profiles
14.9.2 TGV-Laboratories Product Introduction
14.9.3 TGV-Laboratories Dermatomycoses Drug Sales, Revenue (2017-2021)
14.9.4 Strategic initiatives
14.10 Viamet Pharmaceuticals Inc
14.10.1 Viamet Pharmaceuticals Inc Company Profiles
14.10.2 Viamet Pharmaceuticals Inc Product Introduction
14.10.3 Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales, Revenue (2017-2021)
14.10.4 Strategic initiatives
14.11 Vyome Biosciences Pvt Ltd
15. Conclusion

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Dermatomycoses Drug Industry (Volume)
Figure 2. Dermatomycoses Drug Production & Demand by Regions in 2021
Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
Figure 4. The Top 10 and 5 Players Market Share by Dermatomycoses Drug Revenue in 2021
Figure 5. US Dermatomycoses Drug Production, Demand (2017-2027)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Dermatomycoses Drug Production, Demand (2017-2027)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Dermatomycoses Drug Production, Demand (2017-2027)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Dermatomycoses Drug Production, Demand (2017-2027)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Dermatomycoses Drug Production, Demand (2017-2027)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Dermatomycoses Drug Production, Demand (2017-2027)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Dermatomycoses Drug Production, Demand (2017-2027)
Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Dermatomycoses Drug Revenue, by Type (Million USD) (2017-2027)
Table 4. Dermatomycoses Drug Production, by Type (K Unit) (2017-2027)
Table 5. Dermatomycoses Drug Demand (K Unit) by Application (2017-2027)
Table 6. Dermatomycoses Drug Demand (Million USD) by Application (2017-2027)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2021)
Table 9. Regional Market Share in Terms of Revenue (2021&2027)
Table 10. Ranking of Global Top Dermatomycoses Drug Companies by Revenue, Concentration Ratio in 2021
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Dermatomycoses Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Dermatomycoses Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Dermatomycoses Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Dermatomycoses Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Dermatomycoses Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Dermatomycoses Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Dermatomycoses Drug Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Dermatomycoses Drug in US (2017-2021)
Table 53. Market Price (USD/Unit) for Each Type of Dermatomycoses Drug in Europe (2017-2021)
Table 54. Market Price (USD/Unit) for Each Type of Dermatomycoses Drug in China (2017-2021)
Table 55. Market Price (USD/Unit) for Each Type of Dermatomycoses Drug in Japan (2017-2021)
Table 56. Market Price (USD/Unit) for Each Type of Dermatomycoses Drug in India (2017-2021)
Table 57. Market Price (USD/Unit) for Each Type of Dermatomycoses Drug in Korea (2017-2021)
Table 58. Market Price (USD/Unit) for Each Type of Dermatomycoses Drug in Southeast Asia (2017-2021)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Anacor Pharmaceuticals Inc Profiles
Table 61. Anacor Pharmaceuticals Inc Dermatomycoses Drug Product Introduction
Table 62. Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales (Unit), Revenue (Million USD) (2017-2021)
Table 63. Anacor Pharmaceuticals Inc Strategic initiatives
Table 64. Biolab Farmaceutica Ltda Profiles
Table 65. Biolab Farmaceutica Ltda Dermatomycoses Drug Product Introduction
Table 66. Biolab Farmaceutica Ltda Dermatomycoses Drug Sales (Unit), Revenue (Million USD) (2017-2021)
Table 67. Biolab Farmaceutica Ltda Strategic initiatives
Table 68. Blueberry Therapeutics Ltd Profiles
Table 69. Blueberry Therapeutics Ltd Dermatomycoses Drug Product Introduction
Table 70. Blueberry Therapeutics Ltd Dermatomycoses Drug Sales (Unit), Revenue (Million USD) (2017-2021)
Table 71. Blueberry Therapeutics Ltd Strategic initiatives
Table 72. Daewoong Pharmaceutical Co Ltd Profiles
Table 73. Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Product Introduction
Table 74. Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales (Unit), Revenue (Million USD) (2017-2021)
Table 75. Daewoong Pharmaceutical Co Ltd Strategic initiatives
Table 76. Dermala Inc Profiles
Table 77. Dermala Inc Dermatomycoses Drug Product Introduction
Table 78. Dermala Inc Dermatomycoses Drug Sales (Unit), Revenue (Million USD) (2017-2021)
Table 79. Dermala Inc Strategic initiatives
Table 80. Helix BioMedix Inc Profiles
Table 81. Helix BioMedix Inc Dermatomycoses Drug Product Introduction
Table 82. Helix BioMedix Inc Dermatomycoses Drug Sales (Unit), Revenue (Million USD) (2017-2021)
Table 83. Helix BioMedix Inc Strategic initiatives
Table 84. Novan Inc Profiles
Table 85. Novan Inc Dermatomycoses Drug Product Introduction
Table 86. Novan Inc Dermatomycoses Drug Sales (Unit), Revenue (Million USD) (2017-2021)
Table 87. Novan Inc Strategic initiatives
Table 88. Sol-Gel Technologies Ltd Profiles
Table 89. Sol-Gel Technologies Ltd Dermatomycoses Drug Product Introduction
Table 90. Sol-Gel Technologies Ltd Dermatomycoses Drug Sales (Unit), Revenue (Million USD) (2017-2021)
Table 91. Sol-Gel Technologies Ltd Strategic initiatives
Table 92. TGV-Laboratories Profiles
Table 93. TGV-Laboratories Dermatomycoses Drug Product Introduction
Table 94. TGV-Laboratories Dermatomycoses Drug Sales (Unit), Revenue (Million USD) (2017-2021)
Table 95. TGV-Laboratories Strategic initiatives
Table 97. Viamet Pharmaceuticals Inc Profiles
Table 98. Viamet Pharmaceuticals Inc Dermatomycoses Drug Product Introduction
Table 99. Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales (Unit), Revenue (Million USD) (2017-2021)
Table 100. Viamet Pharmaceuticals Inc Strategic initiatives
Table 101. Vyome Biosciences Pvt Ltd Profiles
Table 102. Vyome Biosciences Pvt Ltd Dermatomycoses Drug Product Introduction
Table 103. Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales (Unit), Revenue (Million USD) (2017-2021)